Precision Optics Corporation, Inc.POCI

Precision Optics Corporation, Inc. (POCI) has filed its 10-Q for the quarter ending 31 March 2026, and the numbers are the kind that make even a seasoned filings junkie blink: revenue of $8.7 million materialised alongside a net loss attributable to the parent of $108,283, an operating loss of $64,462, and a diluted loss per share of one cent. Cash and cash equivalents stood at $10.7 million, but net cash used in operating activities was $901,110 for the same three-month window. The company’s assets were $33.7 million with liabilities of $13.6 million, leaving stockholders’ equity at $20.1 million. In short, the optics are clear: the business is haemorrhaging cash while booking paper revenue. (source: 10-Q, period ending 2026-03-31, https://www.sec.gov/Archives/edgar/data/867840/000168316826003818/poci_i10q-033126.htm)

POCI’s product rail is unmistakably medical and industrial: micro-optics lenses and prisms in sub-millimetre sizes, single-use ophthalmic tools, and a custom high-end borescope for jet engines. The company’s own news rail confirms a $3.5 million follow-on production order for a single-use ophthalmic programme and a product development agreement to build a custom borescope for jet engines, both announced on 5 May 2026. On the medical side, POCI partnered with CardioFocus from design through prototyping, clinical trials, and production, now ramping a multi-year, multi-million-dollar programme that relies on high-volume manufacturing and assembly. (source: Press Releases, https://www.poci.com/press-releases/; Medical Device, https://www.poci.com/medical-device/)

The filings also reveal a modest R&D line-$267,319 for the quarter-and a modest capex footprint: $227,209 in property, plant, and equipment capitalised in the prior fiscal year. Inventory crept up $140,349 to $3.7 million, while the company’s cash position declined by $901,110 in operating cash flow. In a sector where precision matters, the filings show precision in the red ink rather than in the bottom line. (source: 10-Q, period ending 2026-03-31, https://www.sec.gov/Archives/edgar/data/867840/000168316826003818/poci_i10q-033126.htm)

POCI’s investor-relations rail points to a podcast, product pages, and newsroom posts, but the SEC filings remain the only place where the company’s financial reality is exposed in full. The source rail provided does not include analyst coverage, valuation commentary, or exchange-level order-book data, so readers seeking intraday liquidity or valuation ranges will find no help here. If you need a chart, the company’s SEC filings are the closest thing to a primary source; anything beyond that is speculation. (source: SEC EDGAR filing index, https://www.sec.gov/edgar/browse/?CIK=867840)

What changed this week: nothing material in the evidence set. The 10-Q for 31 March 2026 is the latest filed financial statement; the 13G/A dated 14 May 2026 is a passive holder update with no trading or ownership implications; the ownership forms dated 1 and 6 April, and 6 May 2026, confirm passive Schedule 13G status for the named filers. In other words, the optics haven’t changed-only the company’s own narrative keeps polishing. (source: 10-Q, period ending 2026-03-31, https://www.sec.gov/Archives/edgar/data/867840/000168316826003818/poci_i10q-033126.htm; SCHEDULE 13G/A, https://www.sec.gov/Archives/edgar/data/867840/000091957426003162/xslSCHEDULE_13G_X02/primary_doc.xml)

What remains unproven: POCI’s ability to convert its $3.5 million order backlog and custom engineering wins into sustained cash generation. The gap between product announcements and cash flow is the real lens through which to view this company. Until operating cash flow turns positive and net income turns black, the filings remain the clearest view. Evidence that would deepen the file: quarterly cash flow statements showing durable operating cash inflows, audited annual filings confirming consistent net income, or a material increase in free cash flow after sustaining capital. For now, the story is the gap. (source: 10-Q, period ending 2026-03-31, https://www.sec.gov/Archives/edgar/data/867840/000168316826003818/poci_i10q-033126.htm)